NXL
Nexalin Technology, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$1.47
−4.55%Price chart
Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4
Key dataNov 4, 2026
Open$1.51
From 52W high−86.58%
Volume7616.00
Market cap$1.54M
P/E (TTM)—
P/S (TTM)7.1x
Div yield—
Key dataNov 4, 2026
Open
$1.51
From 52W high
−86.58%
Volume
7616.00
Market cap
$1.54M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.1x
P/E (TTM)
—
RSI (14)
27.2
MomentumView details →
1D Return
−4.55%
YTD Return
+165.23%
SummaryUpdated Jun 1, 2026
Nexalin Technology, Inc. (NASDAQ:NXL) is a medical device company founded in 2021 and headquartered in Houston, Texas. The company went public in September 2022 and specializes in developing neurostimulation products for treating mental health conditions. Nexalin focuses on non-invasive, drug-free therapeutic devices that use proprietary frequency-based waveforms to stimulate brain structures associated with various mental health disorders.
Similar companies
Latest newsMore news →
Nexalin Technology announced publication of a peer-reviewed analysis reporting that its 15 mA, 40 Hz DIFS stimulation significantly improved sleep quality versus sham in patients with mild Alzheimer's disease, with no serious adverse events.8d agoNexalin Technology, Inc. said it regained compliance with NASDAQ, INC.’s minimum bid price requirement and that a NASDAQ, INC. Hearings Panel granted its request for continued listing.27d ago